On January 14, RH Director Mark Demilio sold 2,254 shares of company stock at an average of $220.00 per share, generating proceeds of $495,880. Following the transaction, Demilio’s direct holdings fell by 10.15% to 19,962 shares, representing an ownership value of approximately $4.39 million. The filing with the SEC underscores a notable reduction in insider conviction at a time when other insiders have maintained or increased their positions.

In its December quarter, RH reported EPS of $1.71, missing analysts’ consensus by $0.42, and delivering revenue of $883.8 million, up 8.9% year-over-year and roughly in line with estimates. Despite top-line growth, net margin stood at just 3.22%, while return on equity was negative 161.7%, pressured by a debt-to-equity ratio exceeding 900%. The company’s current ratio is modest at 1.19, and its quick ratio sits at 0.26, highlighting potential liquidity constraints if operating margins do not improve.

Morgan Stanley raised its price target to $275, citing intact revenue growth and the potential for a multiple re-rating. Conversely, Goldman Sachs cut its target to $144 with a sell rating, while TD Cowen lowered its objective to $200 but maintained a buy rating. Among nine Buy, eight Hold and four Sell ratings, the median target stands near $200, reflecting a polarized outlook where upside catalysts coexist with concerns over leverage and profitability.

Institutional ownership remains high at over 90% of shares outstanding, yet activity has been mixed. Durable Capital Partners increased its stake by 125%, adding 359,101 shares in Q2, while some hedge funds trimmed positions in Q3. Clearstead Advisors boosted its holding by 713% in Q3, though BNP Paribas Asset Management initiated a modest new position. This varied institutional behavior underscores divergent views on RH’s recovery prospects and risk profile.